Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts.

BACKGROUND Millions of postmenopausal women use multivitamins, often believing that supplements prevent chronic diseases such as cancer and cardiovascular disease (CVD). Therefore, we decided to examine associations between multivitamin use and risk of cancer, CVD, and mortality in postmenopausal women. METHODS The study included 161 808 participants from the Women's Health Initiative clinical trials (N = 68 132 in 3 overlapping trials of hormone therapy, dietary modification, and calcium and vitamin D supplements) or an observational study (N = 93 676). Detailed data were collected on multivitamin use at baseline and follow-up time points. Study enrollment occurred between 1993 and 1998; the women were followed up for a median of 8.0 years in the clinical trials and 7.9 years in the observational study. Disease end points were collected through 2005. We documented cancers of the breast (invasive), colon/rectum, endometrium, kidney, bladder, stomach, ovary, and lung; CVD (myocardial infarction, stroke, and venous thromboembolism); and total mortality. RESULTS A total of 41.5% of the participants used multivitamins. After a median of 8.0 years of follow-up in the clinical trial cohort and 7.9 years in the observational study cohort, 9619 cases of breast, colorectal, endometrial, renal, bladder, stomach, lung, or ovarian cancer; 8751 CVD events; and 9865 deaths were reported. Multivariate-adjusted analyses revealed no association of multivitamin use with risk of cancer (hazard ratio [HR], 0.98, and 95% confidence interval [CI], 0.91-1.05 for breast cancer; HR, 0.99, and 95% CI, 0.88-1.11 for colorectal cancer; HR, 1.05, and 95% CI, 0.90-1.21 for endometrial cancer; HR, 1.0, and 95% CI, 0.88-1.13 for lung cancer; and HR, 1.07, and 95% CI, 0.88-1.29 for ovarian cancer); CVD (HR, 0.96, and 95% CI, 0.89-1.03 for myocardial infarction; HR, 0.99, and 95% CI, 0.91-1.07 for stroke; and HR, 1.05, and 95% CI, 0.85-1.29 for venous thromboembolism); or mortality (HR, 1.02, and 95% CI, 0.97-1.07). CONCLUSION After a median follow-up of 8.0 and 7.9 years in the clinical trial and observational study cohorts, respectively, the Women's Health Initiative study provided convincing evidence that multivitamin use has little or no influence on the risk of common cancers, CVD, or total mortality in postmenopausal women.

[1]  J. Manson,et al.  Original Contribution A Prospective Study of Multivitamin Supplement Use and Risk of Breast Cancer , 2008 .

[2]  Elizabeth L. Barry,et al.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. , 2007, JAMA.

[3]  Nih State-of-the-Science Panel.  National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention , 2006, Annals of Internal Medicine.

[4]  J. Wylie-Rosett,et al.  Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.

[5]  Garnet L Anderson,et al.  Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. , 2006, American journal of epidemiology.

[6]  W. Willett,et al.  Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: A pooled analysis of 8 prospective studies , 2006, International journal of cancer.

[7]  Ross L Prentice,et al.  Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. , 2005, American journal of epidemiology.

[8]  J. Manson,et al.  Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial , 2005, JAMA.

[9]  S. Hankinson,et al.  Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. , 2005, Journal of the National Cancer Institute.

[10]  B. Howard,et al.  Antioxidant Vitamin Supplements and Cardiovascular Disease , 2004, Circulation.

[11]  I. Rosenberg,et al.  Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial. , 2004, The American journal of clinical nutrition.

[12]  R. Langer,et al.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.

[13]  M. Thun,et al.  Multivitamin use and colorectal cancer incidence in a US cohort: does timing matter? , 2003, American journal of epidemiology.

[14]  C. Kooperberg,et al.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.

[15]  C. Morris,et al.  Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.

[16]  M. Neuhouser.  Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs. , 2003, The Journal of nutrition.

[17]  J. Manson,et al.  Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. , 2002, Archives of internal medicine.

[18]  A. Folsom,et al.  Relationship of Folate, Vitamin B-6, Vitamin B-12, and Methionine Intake to Incidence of Colorectal Cancers , 2002, Nutrition and cancer.

[19]  Kathleen M. Fairfield,et al.  Vitamins for chronic disease prevention in adults: clinical applications. , 2002, JAMA.

[20]  Kathleen M. Fairfield,et al.  Vitamins for chronic disease prevention in adults: scientific review. , 2002, JAMA.

[21]  M. Thun,et al.  American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity , 2002, CA: a cancer journal for clinicians.

[22]  W. Willett,et al.  The influence of folate and multivitamin use on the familial risk of colon cancer in women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  I. Rosenberg,et al.  Total Homocysteine Lowering Treatment Among Coronary Artery Disease Patients in the Era of Folic Acid-Fortified Cereal Grain Flour , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Thun,et al.  Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States) , 2001, Cancer Causes & Control.

[25]  E. Rimm,et al.  Vitamin supplement use and the risk of non-Hodgkin's lymphoma among women and men. , 2001, American journal of epidemiology.

[26]  I. Rosenberg,et al.  Renal Insufficiency, Vitamin B12 Status, and Population Attributable Risk for Mild Hyperhomocysteinemia Among Coronary Artery Disease Patients in the Era of Folic Acid-Fortified Cereal Grain Flour , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[27]  S. Hendrich,et al.  What do we need to know about active ingredients in dietary supplements? Summary of workshop discussion. , 2001, The Journal of nutrition.

[28]  C. DesRoches,et al.  Americans' views on the use and regulation of dietary supplements. , 2001, Archives of internal medicine.

[29]  J. Hathcock.  Dietary supplements: how they are used and regulated. , 2001, The Journal of nutrition.

[30]  I. Thompson,et al.  Dietary Supplement Use in the Prostate Cancer Prevention Trial: Implications for Prevention Trials , 2001, Nutrition and cancer.

[31]  M. Thun,et al.  Multivitamin use and mortality in a large prospective study. , 2000, American journal of epidemiology.

[32]  C. Hennekens,et al.  Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. , 2000, Annals of epidemiology.

[33]  C. Moore,et al.  Folic Acid for the Prevention of Neural Tube Defects , 1999, Pediatrics.

[34]  R. Patterson,et al.  Motivations for using vitamin and mineral supplements. , 1999, Journal of the American Dietetic Association.

[35]  J. R. Bentley,et al.  American College of Preventive Medicine public policy statement. Folic acid fortification of grain products in the U.S. to prevent neural tube defects. , 1999, American journal of preventive medicine.

[36]  G A Colditz,et al.  Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. , 1999, Journal of the National Cancer Institute.

[37]  A. Kristal,et al.  Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative , 1999, Public Health Nutrition.

[38]  G. Beck,et al.  Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. , 1999, The New England journal of medicine.

[39]  M. Nesheim,et al.  What is the research base for the use of dietary supplements? , 1999, Public Health Nutrition.

[40]  F. Speizer,et al.  Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses' Health Study , 1998, Annals of Internal Medicine.

[41]  D McLerran,et al.  Validity of methods used to assess vitamin and mineral supplement use. , 1998, American journal of epidemiology.

[42]  P Galan,et al.  A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants. , 1998, Controlled clinical trials.

[43]  P. Trumbo,et al.  Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. , 1998, Journal of the American Dietetic Association.

[44]  J. Manson,et al.  Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.

[45]  Edward,et al.  The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  T. Harris,et al.  Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. , 1996, The American journal of clinical nutrition.

[47]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[48]  A. Subar,et al.  Trends in Use of Vitamin and Mineral Supplements in the United States , 1995 .

[49]  T A Colacchio,et al.  A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. , 1994, The New England journal of medicine.

[50]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[51]  R. Peto,et al.  Serum selenium and subsequent risk of cancer among Finnish men and women. , 1990, Journal of the National Cancer Institute.

[52]  E. Yetley.  Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions. , 2007, The American journal of clinical nutrition.

[53]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[54]  C. Swanson,et al.  Relationships of serum carotenoids, retinol, α-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States) , 2004, Cancer Causes & Control.

[55]  M. Thun,et al.  Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  G. Omenn.  Chemoprevention of lung cancer: the rise and demise of beta-carotene. , 1998, Annual review of public health.

[57]  A. Kristal,et al.  Cancer-related behavior of vitamin supplement users. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.